This narrative review catalogs every method for calculating MCID — the smallest patient-reported improvement that actually matters to patients. It asks whether any current method is valid and what a sound method would require. The answer: no single method is sufficient, and MCID's status as a clinical metric is premature.
When you read a spine surgery trial claiming "patients reached MCID on the ODI," the threshold being used was not derived from validated spine-specific data — Copay et al. Confirmed this gap in 2007, and it shapes how critically you should appraise those claims.
In practice: a statistically significant improvement in a large RCT may fall below MCID, meaning real patients would not consider the treatment worthwhile. Conversely, a study underpowered for statistical significance may still show MCID-level improvement in individual patients.
When you see a paper reporting MCID, check which method generated the threshold. Anchor-based thresholds reflect patient perception; distribution-based thresholds reflect measurement reliability. They are not interchangeable, and they will not give you the same number.
The authors' core message: MCID is most useful when framed as the proportion of individual patients who reach the threshold ("responders"), not as an average group change. That framing better reflects whether your next patient is likely to benefit.
This narrative review catalogs every method for calculating MCID — the smallest patient-reported improvement that actually matters to patients. It asks whether any current method is valid and what a sound method would require. The answer: no single method is sufficient, and MCID's status as a clinical metric is premature.
When you read a spine surgery trial claiming "patients reached MCID on the ODI," the threshold being used was not derived from validated spine-specific data — Copay et al. Confirmed this gap in 2007, and it shapes how critically you should appraise those claims.
In practice: a statistically significant improvement in a large RCT may fall below MCID, meaning real patients would not consider the treatment worthwhile. Conversely, a study underpowered for statistical significance may still show MCID-level improvement in individual patients.
When you see a paper reporting MCID, check which method generated the threshold. Anchor-based thresholds reflect patient perception; distribution-based thresholds reflect measurement reliability. They are not interchangeable, and they will not give you the same number.
The authors' core message: MCID is most useful when framed as the proportion of individual patients who reach the threshold ("responders"), not as an average group change. That framing better reflects whether your next patient is likely to benefit.